Aurora Cannabis Target of Unusually Large Options Trading (NASDAQ:ACB)

Aurora Cannabis Inc. (NASDAQ:ACB - Get Free Report) saw unusually large options trading on Monday. Investors purchased 11,137 call options on the company. This represents an increase of approximately 144% compared to the average daily volume of 4,557 call options.

Aurora Cannabis Price Performance

NASDAQ:ACB traded up $0.52 during trading hours on Monday, hitting $3.70. 7,123,641 shares of the company's stock traded hands, compared to its average volume of 990,435. Aurora Cannabis has a twelve month low of $2.84 and a twelve month high of $11.50. The company has a quick ratio of 2.45, a current ratio of 3.79 and a debt-to-equity ratio of 0.14. The stock's fifty day moving average price is $3.76 and its two-hundred day moving average price is $4.77.

Aurora Cannabis (NASDAQ:ACB - Get Free Report) last issued its earnings results on Thursday, February 8th. The company reported ($0.20) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.10). The firm had revenue of $53.34 million during the quarter, compared to analyst estimates of $45.94 million. Aurora Cannabis had a negative return on equity of 23.27% and a negative net margin of 48.82%. On average, sell-side analysts forecast that Aurora Cannabis will post -0.79 EPS for the current fiscal year.

Hedge Funds Weigh In On Aurora Cannabis

Institutional investors have recently bought and sold shares of the business. Advisor Group Holdings Inc. grew its stake in shares of Aurora Cannabis by 9.7% during the first quarter. Advisor Group Holdings Inc. now owns 61,873 shares of the company's stock worth $309,000 after purchasing an additional 5,488 shares during the period. JPMorgan Chase & Co. lifted its holdings in Aurora Cannabis by 824.7% during the first quarter. JPMorgan Chase & Co. now owns 371,269 shares of the company's stock worth $1,485,000 after acquiring an additional 331,120 shares in the last quarter. Raymond James & Associates lifted its holdings in Aurora Cannabis by 93.5% during the first quarter. Raymond James & Associates now owns 32,457 shares of the company's stock worth $130,000 after acquiring an additional 15,687 shares in the last quarter. HighTower Advisors LLC bought a new position in Aurora Cannabis during the first quarter worth about $50,000. Finally, Citigroup Inc. lifted its holdings in Aurora Cannabis by 566.4% during the first quarter. Citigroup Inc. now owns 14,334 shares of the company's stock worth $57,000 after acquiring an additional 12,183 shares in the last quarter. Institutional investors own 11.17% of the company's stock.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group upgraded Aurora Cannabis from a "hold" rating to a "buy" rating in a research report on Friday, February 9th.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.